Arkolith/Insider Trading/KDNY/Form 4

Greenman William Mariner

DirectorCHINOOK THERAPEUTICS, INC. (KDNY) · full profile →Form 4 · filed Aug 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)24K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)3K—$00
Aug 11, 2023Disposed to issuer(D)6K$23.19$138K0
Aug 11, 2023Disposed to issuer(D)4K$35.00$126K0
Aug 11, 2023Disposed to issuer(D)8K—$00
Aug 11, 2023Disposed to issuer(D)3K—$00
Aug 11, 2023Disposed to issuer(D)13K$26.12$347K0
Aug 11, 2023Disposed to issuer(D)4K$7.00$28K0
Aug 11, 2023Disposed to issuer(D)6K$23.55$141K0
Aug 11, 2023Disposed to issuer(D)6K$25.00$150K0
Aug 11, 2023Disposed to issuer(D)24K$25.23$593K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045420) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML